Skip to main content

Table 2 Overview of chromosomal aberrations in SCCs and AKs

From: Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients

 

Type of aberration

Cytoband

Mb location

Size (Mb)

 

SCC_P-03

Loss

4q28.3

1:136,448,440 - 136,988,409

0.54

*

 

Gain

5p

  

*

 

Gain

14q23.1-32.2

14:57,558,740 - 96,468,442

38.9

*

SCC_P-11

Gain

9q

  

*

SCC_P-18

Gain

8q24.22-24.23

8:132,122,430 - 139,467,653

7.3

*

 

Gain

14q13.3

14:71,054,120 - 73,596,540

2.5

 
 

Gain

9p23-tel

9:1–12,039,121

12

*

 

Loss

9p23-cen

 

~40

*

 

Loss

9q

  

*

 

Loss

14q13.3-tel

 

~70

*

 

cnLOH

17

  

*

SCC_P-27

Loss

3p

   
 

Gain

3q

   
 

Loss

4p12-tel

4:1–46,377,946

46,4

*

 

Gain

5q25.3-tel

5:83,159,010 - 100,338,915

17.1

*

 

Loss

6q13-14.1

6:75,600,000 - 76,627,715

1.0

*

 

Loss

9p

   
 

Gain

9q

   
 

cnLOH

18p

   

SCC_P-38

cnLOH

6p21.31-tel

6:1–35,593,684

35.5

 
 

Loss

9p

   
 

Loss

14q

   

SCC_P-41

cnLOH

22q12.1-tel

22:24,348,300 - 49,554,696

25.2

 

AK_P-03

Loss

4q

  

*

 

Loss

5q15-31.1

5:96,745,240 - 133,072,806

36.3

*

 

cnLOH

5q31.1-tel

5:133,268,490 - 180,857,816

47.2

*

 

cnLOH

9q

  

*

AK_P-05

Loss

5q

  

*

 

Loss

9p21.1-tel

9:1–33,109,143

 

*

AK_P-11

Loss

2p22.2-25.1

2:11,690,000 - 36,950,000

25.3

*

 

cnLOH

8p

  

*

 

Loss

13q

  

*

 

Loss

17p

  

*

 

Loss

18q12.1-tel

18:26,013,440 - 76,117,152

50.1

*

AK_P-33

Loss

6q22.31-tel

6:122,757,319 - 170,975,699

48.2

*

AK_P-41

Loss

1p32.3

1:54,783,720 - 55,100,840

0.4

*

 

Loss

3p

   
 

Gain

3q

  

*

 

Loss

4q33-tel

4:171,450,620 - 191,411,215

20.0

 
 

Gain

5q31.2-tel

5:138,387,890 - 180,857,851

42.5

*

 

Loss

8p12-tel

8:1–38,377,990

38.4

 
 

Loss

8q22.1

8:95,250,740 - 96,376,326

1.3

 
 

Loss

9p22.2-cen

9:17,230,530 - 50,549,240

33.3

 
 

Gain

10p

10:1–40,144,085

40.1

*

 

Loss

12q24.23

 

0.5

 
 

Loss

14q

   

AK_P-44

cnLOH

8q33.3-tel

8:126,444,040 - 137,979,818

11.4

 
  1. * heterogeneous chromosomal aberration: observed in less than 70% of the tumor sample.